Rising BioSciences, Inc. Stock OTC Markets

Stocks

RBII

US7676171033

Entertainment Production

OTC Markets Traded
Delayed OTC Markets 14:47:46 2021-10-04 EDT 5-day change 1st Jan Change
0.001000 USD +11.11% Intraday chart for Rising BioSciences, Inc. +400.00% -16.67%
Manager TitleAgeSince
Chief Executive Officer - 2018-11-06
Director of Finance/CFO 77 -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member 77 -
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%+400.00% - - 1.06K
+0.41%+1.49%-23.57%-38.03% 10.99B
-0.30%+8.43%+92.31%+113.69% 9.7B
-2.46%+0.08%-25.71%+15.25% 6.67B
+1.28%-5.46%-45.29%+37.08% 4.73B
-2.05%+2.07%+163.51%+94.19% 4.54B
-0.71%-2.32%-0.94%-6.96% 4.14B
-1.28%-5.12%-32.95%-57.23% 4.08B
-1.30%-14.44%+20.52%-8.04% 3.6B
+2.05%+6.43%-41.11%-19.02% 3.09B
Average +0.67%+0.92%+11.86%+14.55% 5.73B
Weighted average by Cap. -0.49%+1.74%+15.58%+20.19%
Logo Rising BioSciences, Inc.
Rising Biosciences, Inc. is a research and development company. The Company is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The Company operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physician’s practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.
Employees
-